Examining the association between prenatal cannabis exposure and child autism traits: A multi-cohort investigation in the environmental influences on child health outcome program.

Nutor et al. (2024) looked at thousands of mother-child pairs in the United States. They asked if using cannabis during pregnancy raised autism traits or later diagnosis in the kids.

The team counted cannabis use, tobacco use, and many other family factors. They used strong math tools to pull apart cannabis from tobacco and family genetics.

After they removed tobacco and family factors, cannabis showed no link to more autism traits or new diagnoses. The risk line stayed flat.

In plain words: moms who used cannabis did not have children with higher autism scores once the smoke and genes were held steady.

Spriggs et al. (2015) looked smaller and only at preschoolers who already showed autism signs. They saw more anger and sleep problems after cannabis exposure. The new study widened the lens to the full age range and found no rise in traits, suggesting the earlier signal may have come from the narrow group, not the whole population.

Granieri et al. (2020) used the same family-control trick on tobacco. They also saw an early bump in risk vanish after math cleanup. Chaela et al. now repeat that story for cannabis, strengthening the idea that tobacco, not cannabis, was the hidden driver in past reports.

Marí-Bauset et al. (2022) warned that studies on any prenatal chemical often suffer from weak design. The 2024 paper answers that call by adding bigger samples and tighter controls, moving the evidence up a grade.

You can ease parent guilt. When a mom says she used cannabis before she knew she was pregnant, share these data: no rise in autism after tobacco and family factors are ruled out. Shift your intake questions to tobacco and alcohol, where real risk signals still stand. Document cannabis use for honesty, but leave the scare stories at the door.